Sputnik V approved for use in Republic of Maldives
The Russian Direct Investment Fund (RDIF) has announced the approval of the Russian Sputnik V vaccine against coronavirus by the Food and Drug Authority (FDA) of the Republic of Maldives, Trend reports citing TASS.
"FDA granted Sputnik V an emergency use authorization. Thus Sputnik V has been registered in 65 countries with total population of over 3.2 billion people," the Fund said in a statement on Thursday.
Post-vaccination studies in a number of countries demonstrate that Sputnik V is the safest and most effective vaccine against the coronavirus. Sputnik V ranks second among coronavirus vaccines globally in terms of the number of approvals issued by government regulators.